These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17942195)
21. Immunization of HIV-infected adult patients - French recommendations. Frésard A; Gagneux-Brunon A; Lucht F; Botelho-Nevers E; Launay O Hum Vaccin Immunother; 2016 Nov; 12(11):2729-2741. PubMed ID: 27409293 [TBL] [Abstract][Full Text] [Related]
22. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults. Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927 [TBL] [Abstract][Full Text] [Related]
23. Vaccination of the solid organ transplant recipient. Sester M; Gärtner BC; Girndt M; Sester U Transplant Rev (Orlando); 2008 Oct; 22(4):274-84. PubMed ID: 18684606 [TBL] [Abstract][Full Text] [Related]
24. Response to Hepatitis A Vaccination in Immunocompromised Travelers. Garcia Garrido HM; Wieten RW; Grobusch MP; Goorhuis A J Infect Dis; 2015 Aug; 212(3):378-85. PubMed ID: 25649170 [TBL] [Abstract][Full Text] [Related]
25. Pneumococcal immunization in immunocompromised hosts: where do we stand? Cordonnier C; Averbuch D; Maury S; Engelhard D Expert Rev Vaccines; 2014 Jan; 13(1):59-74. PubMed ID: 24308578 [TBL] [Abstract][Full Text] [Related]
26. Influenza vaccination in immunocompromised patients: efficacy and safety. Zbinden D; Manuel O Immunotherapy; 2014; 6(2):131-9. PubMed ID: 24491087 [TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Balfour HH Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447 [TBL] [Abstract][Full Text] [Related]
28. Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines. Koenig HC; Garland JM; Weissman D; Mounzer K AIDS Rev; 2013; 15(2):77-86. PubMed ID: 23681435 [TBL] [Abstract][Full Text] [Related]
30. [Immunization of adults against varicella and herpes zoster]. Hanslik T; Blanchon T; Alvarez FP Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316 [TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study. Kernéis S; Launay O; Ancelle T; Iordache L; Naneix-Laroche V; Méchaï F; Fehr T; Leroy JP; Issartel B; Dunand J; van der Vliet D; Wyplosz B; Consigny PH; Hanslik T Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1522-8. PubMed ID: 23554297 [TBL] [Abstract][Full Text] [Related]
32. [Should we vaccinate patients with systemic lupus]. Wiesik-Szewczyk E; Lacki JK; Chwalińiska-Sadowska H Pol Merkur Lekarski; 2007 Nov; 23(137):395-8. PubMed ID: 18361328 [TBL] [Abstract][Full Text] [Related]
33. Travel-related vaccines. Wilson ME Infect Dis Clin North Am; 2001 Mar; 15(1):231-51. PubMed ID: 11301818 [TBL] [Abstract][Full Text] [Related]
34. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients. Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691 [TBL] [Abstract][Full Text] [Related]
35. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Collaborative Group for Studies with Yellow Fever Vaccine Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925 [TBL] [Abstract][Full Text] [Related]
36. Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases. Small TN; Cowan MJ Expert Rev Clin Immunol; 2011 Mar; 7(2):193-203. PubMed ID: 21426257 [TBL] [Abstract][Full Text] [Related]
37. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893 [TBL] [Abstract][Full Text] [Related]
39. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068. Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I; J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661 [TBL] [Abstract][Full Text] [Related]